HCPCS Q4205 is officially defined as "Membrane graft or membrane wrap, per square centimeter (add-on, list separately in addition to primary procedure)." HCPCS Q4205 is referenced in 4 tracked payer policy changes from Sentara Health Plans, Health Net, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS Q4205 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Starting January 1, 2027, Sentara Health Plans will require prior authorization for a long list of codes on Virginia commercial plans, including self-funded (ASO) plans, and for code 88380 on commercial, Medicaid and Medicare products, plus code 22860 on Medicare products. Sentara will also stop covering a separate list of codes on Virginia commercial and self-funded plans.
Health Net California is updating prior authorization requirements effective December 1, 2025, removing PA requirements for many DME items, prosthetics, sleep studies, varicose vein treatments, and therapy services while maintaining PA requirements for non-emergency air transport, hysterectomies, and skin substitutes. These changes aim to reduce administrative burden and streamline approval processes.
Michigan Medicaid has revised its policy for skin and tissue substitutes, effective June 5, 2026. Coverage is limited to specific diabetic foot ulcers and chronic venous leg ulcers over 4 weeks duration when used with comprehensive standard wound therapy, with strict documentation requirements for all criteria.
Lipectomy or liposuction for lymphedema or lipedema changed from investigational to medically necessary when criteria are met, including significant physical impairment, no response to at least 3 consecutive months of conservative treatment, and continued use of compression garments after surgery. Pharmacy criteria added Valtoco for epilepsy in patients ages 6 and older, required that patients have tried and failed at least one generic anti-seizure medication for Epidiolex, and added Reblozyl for anemia in adults ages 18 and older with beta thalassemia. Coding updates require medical necessity and prior authorization review for CPT 55874 on and after May 17, 2020, removed that review for HCPCS L8692, and require review for investigative status for Q4205, Q4206, Q4208 through Q4219 and Q4221.
Watch Q4205
Get one email when a payer policy names Q4205, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
See every payer rule for Q4205
Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for Q4205 in one place.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.